Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2012
06/07/2012WO2012072033A1 Substituted 2,3-phthalazinone compounds and use thereof
06/07/2012WO2012071980A1 Preparation method of α-imatinib mesylate
06/07/2012WO2012071684A1 Heterocyclic derivates，preparation processes and medical uses thereof
06/07/2012WO2012052746A3 Method and device for the detection of sulphur containing species
06/07/2012WO2012044727A3 Manufacturing process for pyrimidine derivatives
06/07/2012WO2012044046A3 Novel methylcyclohexane derivatives and uses thereof
06/07/2012WO2012026766A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2012026765A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2010073128A3 Fused imidazole derivatives as trpv3 antagonist
06/07/2012US20120142932 Method for manufacturing 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivative
06/07/2012US20120142930 N-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for the identification of biological and pharmacological activity
06/07/2012US20120142922 Benzamide derivatives
06/07/2012US20120142921 Substituted hydrazide compounds and use thereof
06/07/2012US20120142738 Pharmaceutical composition for treating dermatological autoimmune diseases
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142709 Substituted pyridinone-pyridinyl compounds
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142706 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
06/07/2012US20120142705 Isatin and oxindole compounds
06/07/2012US20120142698 Microbiocidal heterocycles
06/07/2012US20120142697 Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142695 Compounds as bradykinin b1 antagonists
06/07/2012US20120142694 Substituted 4-hydroxypyrimidine-5-carboxamides
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142688 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142668 Cathepsin c inhibitors
06/07/2012US20120142667 Pyrimidine derivatives as zap-70 inhibitors
06/07/2012US20120139410 Organic electroluminescence device and material for organic electroluminescence device
06/07/2012US20120138912 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
06/07/2012US20120138877 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
06/07/2012CA2820550A1 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
06/07/2012CA2819734A1 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012CA2819508A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012CA2819468A1 Chemokine cxcr4 receptor modulators and used related thereto
06/07/2012CA2819410A1 Heterocyclic derivates, preparation processes and medical uses thereof
06/06/2012EP2461390A1 Organic electroluminescent element
06/06/2012EP2460801A1 Bicyclic compound and use thereof for medical purposes
06/06/2012EP2460798A2 Apaf-1 inhibitor compounds
06/06/2012EP2460796A1 Indole derivative
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof
06/06/2012EP2459551A1 Dihydrobenzoindazoles
06/06/2012EP2459549A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/06/2012EP2459548A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/06/2012EP2459547A1 Herbicidally active heteroaryl-substituted cyclic diones or derivatives thereof
06/06/2012EP2459541A1 Dihydropyrimidone amides as p2x7 modulators
06/06/2012EP2459537A2 Method and substances for preparation of n-substituted pyridinium compounds
06/06/2012EP2459535A1 Pyridine and pyrazine derivatives as protein kinase modulators
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012EP2231640B1 Beta-amino acid derivatives for treatment of diabetes
06/06/2012EP1858879B1 1,3-diaryl substituted ureas as modulators of kinase activity
06/06/2012EP1751149B1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
06/06/2012EP1685125B1 Pyrrole derivatives useful for the treatment of proliferative diseases
06/06/2012EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors
06/06/2012CN1342158B 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
06/06/2012CN102485721A Substituted 2,3-phthalazinone compounds and application thereof
06/06/2012CN102485720A Heat shock protein 90 inhibitor
06/06/2012CN102485719A Preparation method of Imatinib amine
06/06/2012CN101848893B 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
06/06/2012CN101522668B Oxyindole derivatives as 5ht4 receptor agonists
06/06/2012CN101472904B Diazepan derivatives modulators of chemokine receptors
06/06/2012CN101417995B Phenoxy pyrimidine derivates and preparation method and use thereof
06/06/2012CN101213192B Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
06/06/2012CN101213187B Isoquinoline derivatives as inhibitors of RHO-kinase
06/06/2012CN101098855B 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
06/06/2012CN101039933B Diaminotriazole compounds useful as protein kinase inhibitors
06/05/2012US8193369 Benzimidazole cannabinoid agonists
06/05/2012US8193352 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/05/2012US8193349 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193228 Substituted imidazole as bombesin receptor subtype-3 modulators
06/05/2012US8193219 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
06/05/2012US8193218 Aroyl-piperidine derivatives and method of treating disorders induced by substance P
06/05/2012US8193217 Polymorphic form of granisetron hydrochloride and methods of making the same
06/05/2012US8193205 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
06/05/2012US8193198 Uracil compounds and a herbicide comprising the same
06/05/2012US8193194 Ion channel modulators and methods of use
06/05/2012US8193192 Heterocyclic FXR binding compounds
06/05/2012US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits
06/05/2012US8193182 Substituted isoquinolin-1(2H)-ones, and methods of use thereof
06/05/2012US8191802 Aerosol
06/05/2012CA2681809C Imidazolidinone derivatives
06/05/2012CA2661861C Heterocyclic fxr binding compounds
06/05/2012CA2596013C Benzoimidazole derivatives and pharmaceutical composition comprising the same
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/05/2012CA2520000C Compositions and methods for treating cancer
06/05/2012CA2475766C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012070700A1 Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012069948A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 1080